Fabian Hansen

Fabian Hansen is a prominent venture capitalist and investor based in San Francisco, California. He is best known as the co-founder and General Partner of Presight Capital, a $700 million venture fund that invests in ambitious founders worldwide from seed stage to IPO.1

Professional Experience

Hansen has an impressive track record in the investment and startup ecosystem:

Presight Capital:

• Co-founder and General Partner since January 20191

Board Memberships: Hansen serves on the boards of several innovative companies:

• Alloy Therapeutics, Inc. (since February 2021)
• Peptilogics (since December 2020)
• Angiex Inc. (since March 2021)
• A stealth biotech startup (since September 2020)1

He was also previously a board member at VALOREO, a Latin American e-commerce conglomerate, until its exit to Razor in January 2023.1

Investment Focus

Hansen has shown particular interest in:

• Biotechnology and healthcare startups
• E-commerce and consumer brands
• Early-stage technology companies12

Education

• Master of Science (MSc.) from The London School of Economics and Political Science (LSE)
• Bachelor of Science (BSc.) from Royal Holloway, University of London1

Languages

Hansen is multilingual, with native or bilingual proficiency in:

• English
• Italian
• German1

While the query mentions TERN Group, the available search results do not provide specific information about Hansen's involvement with this organization. His LinkedIn profile primarily highlights his role at Presight Capital and other board memberships.